Keywords: update, mixed, reaction, shire, 6b, bid, tkt

UPDATE: Mixed reaction to Shire's $1.6B bid for TKT

Article | 27 April 2005

Print This

The news that UK-based Shire Pharmaceuticals has signed a definitive agreement to acquire US firm Transkaryotic Therapies, in an all-cash ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in